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Introduction
While transfusion-associated infections have globally decreased over the past 50 years, bacterial contamination of the platelet supply remains a significant public health challenge, with approximately one in 1,500 -5,000 units containing detectable organisms [1] [2] [3] [4] [5] . Room temperature storage facilitates more bacterial growth in platelets compared to other blood products, with skin flora, asymptomatic donor bacteremia, and direct introduction from environmental sources accounting for the majority of contaminants 3, 6 . Even though current culture-based screening approaches may miss a significant fraction of contaminated units, clinically reported sepsis occurs in only one in 15,000-100,000 transfusions, presumably due to frequent concurrent antibiotic administration, low bacterial inoculum, or attribution of transfusionrelated outcomes to a patient's pre-existing infection or illness 3, 7 .
Pathogen-reduction of platelet products using amotosalen, a nucleic acid cross-linking agent activated by ultraviolet (UV)-A irradiation, has been routinely performed in Europe for over a decade and recently received United States Food and Drug Administration approval 8 .
Photoinactivation is broadly effective against diverse bacterial pathogens, and while failure at high bacterial loads has been described, few reports of sepsis have been reported following treatment 9, 10 .
Here we describe three transfusion-related Gram-negative sepsis investigations including one involving a pathogen-reduced platelet product. For each, we performed metagenomic next generation sequencing (mNGS) in addition to standard microbiologic diagnostics and found that mNGS enabled rapid and precise taxonomic identification and phylogenetic analysis of bacterial isolates, as well as culture-independent assessment of direct clinical samples.
Methods

Ethics Statement
Investigations were carried out according to a no-subject-contact study protocol approved by the UCSF Institutional Review Board (IRB# 17-24056) which permitted analysis of de-identified leftover clinical microbiology samples from collaborating institutions and subsequent review of study subjects' electronic medical records.
Microbial culture
Bacterial cultures were inoculated into BacT/Alert (bioMérieux) blood culture bottles using standard clinical protocols. Species identification was performed using MALDI-TOF mass spectrometry (Bruker).
Sequencing and sample processing
Metagenomic sequencing was completed prior to bacterial isolate whole genome sequencing, to eliminate the possibility of contaminating metagenomic samples with isolate nucleic acid. All samples (culture-free plasma and blood product samples as well as cultured isolates) were inactivated by adding either DNA/RNA Shield (Zymo Research, Irvine, CA) or an extraction kit lysis buffer, and bashed with ceramic beads on a TissueLyser (Qiagen, Hilden, Germany) for either 2 minutes at 15s -1 
Bioinformatics and phylogenetic analyses
Detection, taxonomic identification, and abundance quantitation of microbes from raw sequencing reads was first performed using the IDseq pipeline according to described protocols 12 . To control for background environmental and reagent contaminants, no-template water control samples were incorporated alongside extracted nucleic acid and carried forward throughout library preparation and sequencing. Genome assembly was performed by first trimming the raw sequencing reads in fastq files using TrimGalore 17 and assembling using Unicycler 18 with default parameters. To identify the Acinetobacter species in case 1, BLAST+ 19 was used to query the National Center for Biotechnology Information (NCBI) nt database with the assembled genomes, and related genomes were found using a Mash/Mini Hash search via PATRIC 20,21 . For case 3 samples, sequence type was determined using SRST2 22 ; other Klebsiella pneumoniae sequences in NCBI databases belonging to the same sequence type were found using a Mash/Mini Hash search via PATRIC 20,21 .
Phylogenetic analysis for case 1 and case 3 was used to determine the relationship between the samples in this study and the closely related NCBI samples. First, trimmed reads were aligned against a reference genome (case 1: A. baumannii CP017642.1, case 3: K. pneumoniae CP015392.1) using Snippy v4.3.6 23 . Then a SNP alignment was obtained by variant calling using bcftools v1.9 24 . We filtered SNPs with QUAL<30, and filtered genotypes with major allele depth (FMT/AD) < 10 or major allele frequency (FMT/AF) < .9. Finally, the maximum likelihood phylogeny based on the SNP alignments was built in RAxML v8.2.12 25 using '-m ASC_GTRCAT --asc-corr=lewis' options.
Data Availability
Raw sequencing data is available via NCBI BioProject ID: PRJNA544865.
Results
Investigation #1: Acinetobacter septic platelet transfusion
Patient A, a man with relapsed acute lymphoblastic leukemia undergoing chemotherapy, received two doses of pathogen-reduced apheresis platelets on the day of planned home discharge. No side effects were experienced after transfusion of the first platelet unit, however after receiving the second unit two hours later, he developed chills and rigors followed by fever and critical hypotension. He received fluids and vancomycin before being transferred to the intensive care unit where meropenem, vasopressors, respiratory support and continuous renal replacement therapy were administered. He recovered fully and was discharged home 16 days later on parenteral antibiotics. To investigate this case further, we first sequenced the cultured ACB complex isolate from the patient's blood and the ACB complex isolate from a wash of the transfused platelet bag. In total, sequencing and analysis for this case was performed in 45 hours. De novo genome assembly revealed a novel Acinetobacter species most closely related (92% average nucleotide identity) to A. nosocomialis and A. pitii, members of the ACB complex ( Figure 1A) .
Phylogenetic analysis revealed zero single nucleotide polymorphisms (SNPs) over the 3.9 Mb genome between the novel Acinetobacter species cultured from the blood and from the platelet bag, indicating that the two isolates were identical. 1 1 Culture-independent mNGS detected a high abundance of ACB complex in the transfused product (230,000 reads per million, rpM) and in the patient's plasma following transfusion (190 rpM) ( Figure 1B) . By comparison, the untransfused co-components and patient's plasma before transfusion had very few alignments to ACB complex, in the range of expected background levels (0.25 and 2.2 rpM, respectively). Assessment of these low abundance alignments at the species level revealed that they most likely represented misassigned reads from other Acinetobacter species, notably A. johnsonii. More specifically, the co-components and pre-transfusion samples had only a small percentage of Acinetobacter genus reads that best aligned to an ACB species, while in the transfused product and posttransfusion samples, the vast majority of genus Acinetobacter reads aligned to ACB species (eFigure 1A). The orders-of-magnitude difference in percent reads mapping to ACB complex, along with the change in composition of Acinetobacter assignments between samples, indicated that only the transfused product and patient's post-transfusion plasma were contaminated by a species within the ACB complex.
Investigation #2: Fatal Pseudomonas aeruginosa septic transfusion
Patient B was admitted for management of acute on chronic heart failure and implantation of a right ventricular assist device. During surgery, the patient received three units of platelets, three units of fresh frozen plasma, and two units of cross-matched packed red blood cells (PRBCs). Intraoperatively, the patient became hemodynamically unstable. Cultures drawn three hours post-surgery ultimately returned positive for Pseudomonas aeruginosa, raising concern for a septic transfusion reaction (Figure 2) . The sequence type of K. pneumoniae in all four samples was determined to be ST491, and the closest ST491 sequence on Genbank differed from these sequences by 212 SNPs.
Together these data confirmed that the platelet unit represented a single source of infection and that despite Patient D having negative blood cultures, both patients became bacteremic with the same strain of K. pneumoniae transfused from the contaminated platelet components. As previously reported, routine culture-based screening of the donor's platelets at 24 hours remained negative at five days, although an additional platelet unit from the same donor shipped to a different hospital and quarantined before transfusion grew K. pneumonaie that was highly related based on whole genome sequencing analysis 6 .
Discussion
Bacterial contamination of platelet products remains an important and underrecognized hospital infection control challenge despite existing screening methods and psoralen-based pathogen-reduction strategies [1] [2] [3] [4] [5] . Rapid recognition of potential transfusion-associated sepsis can permit quarantine of untransfused co-components from a potentially contaminated supply chain and assist with root cause analysis. Traditionally, culture-based methods including pulsedfield gel electrophoresis and more recently, whole genome sequencing, have been the central diagnostic tools for septic transfusion investigations. Here, we found that culture-independent mNGS extended the utility of these methods by directly detecting pathogens from clinical samples to assess genetic relatedness, obtain precise strain information, and interrogate levels of pathogen in a patient's bloodstream throughout the course of a septic transfusion event.
In each case examined, mNGS provided actionable information that clarified the sequence of events resulting in transfusion-related sepsis. In case 1, for example, potential explanations considered included: 1) failure of the pathogen inactivation process; 2) contamination of the platelet bag from an environmental source after pathogen reduction; and 3)
pre-existing occult bacteremia resulting in retrograde introduction of bacteria into the platelet bag during transfusion. Temporal mNGS assessment of patient plasma demonstrated abundant
Acinetobacter DNA in post-transfusion samples and in washes of the transfused platelet bag, but not in any pre-transfusion samples, consistent with a septic transfusion event and not preexisting bacteremia. The findings of high abundance Acinetobacter sp. in the transfused unit but not untransfused co-components suggested that contamination occurred following pathogen reduction treatment, potentially from an environmental source during product handling, transport or storage. Transfusion-related sepsis from pathogen-reduced platelet products has been reported but is extremely rare 9, 10 . This case suggests that pathogen reduction technology should still be accompanied by rigorous infection control precautions during downstream processing, transport and storage.
In case 2, the possibility of an occult but developing bloodstream infection present prior to transfusion was also considered as a potential explanation for the patient's post-surgical sepsis. As in case 1, assessment of plasma samples collected before and after transfusion clarified the sequence of events and demonstrated that P. aeruginosa was only detectable posttransfusion. Evidence for a septic transfusion event was further corroborated by temporal measurement of procalcitonin, a host inflammatory biomarker with specificity for bacterial infection 13, 14 . Post-transfusion procalcitonin levels above the upper limit of detection in the context of normal pre-surgical levels provided further evidence that a septic transfusion event had occurred. The absence of detectable P. aeruginosa in the transfused PRBC segments suggested that platelets or plasma may have been the source of contamination, although neither sample type was available for confirmation.
Discovery that the implicated pathogen in case 1 represented a novel species of
Acinetobacter highlights the ability of sequencing-based diagnostics to extend our understanding of pathogens responsible for transfusion-related infections. Notably, the standard clinical microbiology workflow at the study site hospital involving culture, biochemical testing and matrix associated laser desorption ionization (MALDI) time of flight (TOF) mass spectrometry was unable to distinguish this Acinetobacter as a novel species.
All three cases notably demonstrated that mNGS afforded high resolution taxonomic identification without a need to isolate a pathogen in culture. This allowed for post-hoc analyses of banked clinical specimens obtained both pre-and post-transfusion that were either unsuitable or unavailable for culture. For instance, even though no cultured isolates were available in case 2, direct mNGS of leftover blood products allowed for precise identification of the most closely related Pseudomonas aeruginosa strain, which incidentally was recovered in 2013 from a patient's wound in Massachusetts, USA.
Confirming transmission of a pathogen during septic transfusion events is essential for hospital infection control, but in some cases is not possible because culture fails to identify a microbe. This problem was highlighted by case 3, in which blood cultures from patient D remained negative despite the development of post-transfusion septic shock. Patient D was receiving a prophylactic antibiotic with activity against Klebsiella, which likely inhibited bacterial growth in culture, precluding definite confirmation of a septic transfusion event related to that experienced by Patient C. Culture-independent mNGS not only confirmed the presence of K. in the blood of both patients but also established that it was identical to the isolate derived from transfused platelet product. This unfortunate fatal transfusion case demonstrated the capability of mNGS to provide definitive confirmation and characterization of septic transfusion events in cases where culture fails to yield an isolate.
Acinetobacter and Pseudomonas are environmentally ubiquitous and common contaminants of mNGS and 16S rRNA gene sequencing library preparation reagents 11, 16 , and as such can add considerable complexity to investigations in which accurately assessing the abundance of transfused pathogens belonging to these genera is critical. To address this, we employed two complementary approaches that may be broadly useful for future investigations: 1) assessing compositional changes of species within the relevant genus as a proxy for environmental contamination, and 2) focusing analysis exclusively on the exact species implicated in the transfusion event. In case 1, for example, these approaches clarified that the novel Acinetobacter species was present only in the residual transfused product and in the patient's plasma following transfusion, but not in the other co-components nor in the patient's bloodstream prior to the event.
Rapid assessment of septic transfusion events is critical to ensure related contaminated products can be swiftly quarantined, and probable sources of contamination identified. We found that mNGS and pathogen analysis could be reliably performed in under 48 hours, faster than the turnaround time for blood culture at many institutions. Cost, time and infrastructure requirements currently make sequencing impractical at many healthcare institutions, however 1 7 new platforms such as the Illumina iSeq and Oxford Nanopore Minion will undoubtedly increase the broad applicability of this technology for rapid hospital epidemiologic investigations.
As genomic approaches become more widely used for investigating transfusion- In summary, transfusion-related sepsis continues to cause excess mortality and morbidity despite the introduction of pathogen-reduction technologies. We found that cultureindependent mNGS complemented current best available methods for investigation of 
